Results of Infrapopliteal Endovascular Procedures Performed in Diabetic Patients with Critical Limb Ischemia and Tissue Loss from the Perspective of an Angiosome-Oriented Revascularization Strategy

Table 2

TASC-II classification for the worst lesion treated and perioperative data of the subjects included.

Perioperative data	𝑛=101
TASC-B	6 (5.9%)
TASC-C	15 (14.9%)
TASC-D	80 (79.2%)
Combined treatment*	56 (55.4%)
Debridement	11 (10.9%)
Minor amputation	28 (27.7%)
Multiple revascularization	52 (51.5%)
Runoff 0	16 (15.8%)
Runoff 1	64 (63.4%)
Runoff > 1	21 (20.8%)
DR^#	46 (54.1%)
IR^† “through collaterals”	22 (25.9%)
IR^† “without collaterals”	17 (20.0%)
Postoperative ABI^&	0.84 (0.69–0.93)
MACE^+ at 30 days	3 (3.0%)
MALE^μ at 30 days	3 (3.0%)
Major amputation at 30 days	2 (2.0%)

*Combined treatment: combined treatment of the femoropopliteal and the infrapopliteal sector; ^#DR: direct revascularization; ^†IR: indirect revascularization; ^&ABI: ankle-brachial index; ⁺MACE: major adverse cardiovascular event; ^μMALE: major adverse limb event.